This topic contains a solution. Click here to go to the answer

Author Question: What is another characteristic of an organizations that possesses a favorable task environment? ... (Read 192 times)

hbsimmons88

  • Hero Member
  • *****
  • Posts: 526
What is another characteristic of an organizations that possesses a favorable task environment?
 
  A. Excellent facilities
   B. A well-educated staff
   C. A mission that is legitimized by the task environment
   D. A bureaucratic organizational structure

Question 2

Which of the following is a characteristic of an organization that possesses a favorable task environment?
 
  A. It is funded by tax money.
   B. People believe that they or someone they care about might someday benefit from its services.
   C. It uses a new and innovative approach to some problem.
   D. It offers services to its clients, free-of-charge.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

maya.nigrin17@yahoo.com

  • Sr. Member
  • ****
  • Posts: 324
Answer to Question 1

C

Answer to Question 2

B




hbsimmons88

  • Member
  • Posts: 526
Reply 2 on: Jul 6, 2018
Wow, this really help


komodo7

  • Member
  • Posts: 322
Reply 3 on: Yesterday
Excellent

 

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

The first documented use of surgical anesthesia in the United States was in Connecticut in 1844.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library